Federal Register of Legislation - Australian Government

Primary content

PB 66 of 2023 Determinations/Health as made
This instrument amends the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021 by adding a different form of insulin degludec with insulin aspart that is currently subject to a Therapeutic Goods Administration (TGA) Serious Scarcity Substitution Instrument (SSSI). This allows supplies made under the TGA SSSI to be subsidised under the Pharmaceutical Benefits Scheme.
Administered by: Health and Aged Care
Registered 05 Jul 2023
Tabling HistoryDate
Tabled HR31-Jul-2023
Tabled Senate31-Jul-2023
Date of repeal 15 Sep 2023
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

Commonwealth Coat of Arms of Australia

 

National Health (Pharmaceutical Benefits)

(Pharmacist Substitution of Medicines without

Prescription during Shortages) Amendment (No. 4) Determination 2023

I, Nikolai Tsyganov, as delegate of the Minister for Health and Aged Care, make the following determination.

Dated 5 July 2023

 

 

 

Nikolai Tsyganov

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

 


Contents

1......... Name............................................................................................................................... 1

2......... Commencement............................................................................................................... 1

3......... Authority......................................................................................................................... 1

4......... Schedules......................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021

 

 


1  Name

(1)    This instrument is the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Amendment (No. 4) Determination 2023.

(2)    This instrument may also be cited as PB 66 of 2023.

2  Commencement

(1)    Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

 

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

6 July 2023

6 July 2023

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)    Any information in column 3 of the table is not part of this instrument.

Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                    This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

National Health (Pharmaceutical Benefits) (Pharmacist Substitution of

Medicines without Prescription during Shortages) Determination 2021

Subsection 5(8), after item 46 dealing with Cefaclor

Insert:

47

Listed drug:  Insulin degludec with insulin aspart

Form:   Injections, pre-filled pen, 70 units-30 units per mL, 3 mL, 5

Manner of administration: Injection

Brand:  Ryzodeg Flextouch

Listed drug:  Insulin degludec with insulin aspart

Form:   Injections, cartridges, 70 units-30 units per mL, 3 mL, 5

Manner of administration: Injection

Brand:  Ryzodeg Penfill